Stemline Therapeutic (STML) Stock Analyst Ratings
NASDAQ:STML - Nasdaq -
ChartMill assigns a Buy % Consensus number of 77% to STML. The Buy consensus is the weighted average rating of the current analysts ratings.
STML was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about STML.
In the previous month the buy percentage consensus was at a similar level.
STML was analyzed by 7 analysts. More opinions would make the average more meaningful.